Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MLYCD | O95822 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21541951 | 1.00 | HPGD (0.67) | HPGDP2RX7KMT2ATSHRKDM4E | |
| SCHEMBL20477558 | 1.00 | HPGD (0.67) | HPGDP2RX7KMT2ATSHRKDM4E | |
| SCHEMBL29418612 | 1.00 | HPGD (0.67) | HPGDP2RX7KMT2ATSHRKDM4E | |
| SCHEMBL20477540 | 0.83 | HPGD (0.63) | HPGDPOLBSCN9A | |
| SCHEMBL29418710 | 0.83 | HPGD (0.63) | HPGDPOLBSCN9A | |
| SCHEMBL20477566 | 0.83 | HPGD (0.63) | HPGDPOLBSCN9A | |
| SCHEMBL29418763 | 0.83 | HPGD (0.63) | HPGDPOLBSCN9A | |
| Bimokalner SCHEMBL22017037 | 0.81 | HPGD (0.67) | HPGDKMT2AKDM4EMEN1POLB | |
| Bimokalner SCHEMBL20477551 | 0.81 | HPGD (0.67) | HPGDKMT2AKDM4EMEN1POLB | |
| Bimokalner SCHEMBL20477545 | 0.81 | HPGD (0.67) | HPGDKMT2AKDM4EMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4247332-B1 | NON-AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2026-04-22 | — | — | EP | claimed |
| US-20260083669-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2026-03-26 | — | — | US | claimed |
| CN-117881393-A | Aqueous gel composition | 阿库西亚医疗有限责任公司 | 2024-04-12 | — | — | CN | claimed |
| CN-116600787-A | Nonaqueous gel composition | 阿库西亚医疗有限责任公司 | 2023-08-15 | — | — | CN | claimed |
| CN-110312710-B | Compounds useful as potassium channel openers | 阿库西亚医疗有限责任公司 | 2022-02-15 | — | — | CN | claimed |
| US-20260083669-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
| CN-114105942-B | Compounds useful as potassium channel openers | 阿库西亚医疗有限责任公司 | 2024-07-12 | — | — | CN | disclosed |
| EP-4362916-A1 | AQUEOUS GEL COMPOSITION | Acousia Therapeutics GmbH (DE) | 2024-05-08 | — | — | EP | disclosed |
| CN-117881393-A | Aqueous gel composition | 阿库西亚医疗有限责任公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2023222795-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2023-11-23 | — | — | WO | disclosed |
| CN-116600787-A | Nonaqueous gel composition | 阿库西亚医疗有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-110312710-B | Compounds useful as potassium channel openers | 阿库西亚医疗有限责任公司 | 2022-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083669-A1 | AQUEOUS GEL COMPOSITION | CFTR, AQP3, SLC26A4 | HPGD 1470/4885P2RX7 559/4885KMT2A 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.